Back

An immune checkpoint inhibitor-related effusive-constrictive pericarditis as a part of a wide range multi-organ immune-related phenomena

21 June 2025 (10:23 - 10:32)
Organised by: Logo
Congress Presentation Part of: From the clinic to Florence: experiences at the frontline of cardio-oncology (4) Cardio-Oncology CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Doctor Danae Garcia Cosculluela

UNIVERSITY HOSPITAL MUTUA DE TERRASSA, Terrassa (Spain)

4 More presentations in this session

Presentation thumbnail
Heart transplantation as an effective alternative in the treatment of cardiotoxicity
Mrs A. Nepomuceno Cunha (Sao Paulo, BR)
Slides Video
Presentation thumbnail
Fatal pulmonary hypertension in advanced lung adenocarcinoma: a possible complication of serial tyrosine kinase inhibitor therapy
Doctor Y. Hung (Taipei, TW)
Slides Video
Presentation thumbnail
Managing ICI-myocarditis in metastatic melanoma: a case of steroid resistance and response to ruxolitinib
Doctor K. Ozaeta (London, GB)
Slides Video
Presentation thumbnail
Primary cardiac lymphoma presenting as acute coronary syndrome and complete heart block - nodal disease of a different type.
Doctor A. Kulek (Stony Brook, US)
Slides

Access the full session

Session thumbnail
From the clinic to Florence: experiences at the frontline of cardio-oncology (4)

The Event

Event poster

ESC Cardio-Oncology 2025

21 June 2025 10:23 CET
You may be interested in
thumbnail
Congress Presentation
Immune-related constrictive pericarditis induced by pembrolizumab: a clinical challenge in managing inflammation and heart failure
thumbnail
Congress Session
Cardio-oncology emergencies: immune checkpoint inhibitor myo-pericarditis, failure, and shock
thumbnail
Congress Session
Immune checkpoint inhibitors and the heart

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources